Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Daniela Manno 
;
Philip Ayieko;
David Ishola;
Muhammed O Afolabi ;
Baimba Rogers;
Frank Baiden;
Alimamy Serry-Bangura;
Osman M Bah;
Brian Köhn;
Ibrahim Swaray;
+14 more...
Kwabena Owusu-Kyei;
Godfrey T Otieno;
Dickens Kowuor;
Daniel Tindanbil;
Elizabeth Smout;
Cynthia Robinson;
Babajide Keshinro;
Julie Foster;
Katherine Gallagher ;
Brett Lowe;
Macaya Douoguih;
Bailah Leigh;
Brian Greenwood ;
Deborah Watson-Jones ;
(2022)
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Emerging Infectious Diseases, 28 (3).
pp. 734-738.
ISSN 1080-6040
DOI: 10.3201/eid2803.211496
;
Philip Ayieko;
David Ishola;
Muhammed O Afolabi ;
Baimba Rogers;
Frank Baiden;
Alimamy Serry-Bangura;
Osman M Bah;
Brian Köhn;
Ibrahim Swaray;
+14 more...
Kwabena Owusu-Kyei;
Godfrey T Otieno;
Dickens Kowuor;
Daniel Tindanbil;
Elizabeth Smout;
Cynthia Robinson;
Babajide Keshinro;
Julie Foster;
Katherine Gallagher ;
Brett Lowe;
Macaya Douoguih;
Bailah Leigh;
Brian Greenwood ;
Deborah Watson-Jones ;
(2022)
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone.
Emerging Infectious Diseases, 28 (3).
pp. 734-738.
ISSN 1080-6040
DOI: 10.3201/eid2803.211496
We explored the association of Ebola virus antibody seropositivity and concentration with potential risk factors for infection. Among 1,282 adults and children from a community affected by the 2014-2016 Ebola outbreak in Sierra Leone, 8% were seropositive for virus antibodies but never experienced disease symptoms. Antibody concentration increased with age.
-
picture_as_pdf - Manno_etal_2022_Ebola-virus-glycoprotein-igg-seroprevalence.pdf
-
subject - Published Version
-
- Available under Creative Commons: 4.0
Downloads